These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8738844)

  • 1. Antibacterial in vitro activity of fourth generation cephalosporins.
    Hancock RE; Bellido F
    J Chemother; 1996 Feb; 8 Suppl 2():31-6. PubMed ID: 8738844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newer antipseudomonal cephalosporins.
    Watanabe NA
    J Chemother; 1996 Feb; 8 Suppl 2():48-56. PubMed ID: 8738846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity, pharmacokinetics, clinical efficacy, safety and pharmacoeconomics of ceftriaxone compared with third and fourth generation cephalosporins: review.
    Bijie H; Kulpradist S; Manalaysay M; Soebandrio A
    J Chemother; 2005 Feb; 17(1):3-24. PubMed ID: 15828439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Third-generation cephalosporins resistance in clinical isolates of Enterobacteriaceae.
    Perduca M; Pagani L; Cereda PM; Debiaggi M
    Microbiologica; 1986 Apr; 9(2):199-207. PubMed ID: 3487023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory activity and resistance to hydrolysis by beta-lactamases of some (D,L)-7-(alpha-fluoroacylamino)cephalosporins.
    Somma S; Malabarba A; Gastaldo L; Cavalleri B
    Farmaco Sci; 1984 May; 39(5):463-72. PubMed ID: 6376165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial resistance to cephalosporins as a function of outer membrane permeability and access to their target.
    James PA; Reeves DS
    J Chemother; 1996 Feb; 8 Suppl 2():37-47. PubMed ID: 8738845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E
    Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefepime: the next generation?
    Sanders CC
    Clin Infect Dis; 1993 Sep; 17(3):369-79. PubMed ID: 8218678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic and genotypic detection of ESBL mediated cephalosporin resistance in Klebsiella pneumoniae: emergence of high resistance against cefepime, the fourth generation cephalosporin.
    Grover SS; Sharma M; Chattopadhya D; Kapoor H; Pasha ST; Singh G
    J Infect; 2006 Oct; 53(4):279-88. PubMed ID: 16488476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicentre study of the in vitro activity of cefepime, a broad-spectrum cephalosporin, compared to other broad-spectrum agents.
    Bell JM; Turnidge JD;
    Pathology; 2001 Feb; 33(1):53-60. PubMed ID: 11280610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the mechanism of resistance to third-generation cephalosporins by class C beta-lactamases by using chemical complementation.
    Carter BT; Lin H; Goldberg SD; Althoff EA; Raushel J; Cornish VW
    Chembiochem; 2005 Nov; 6(11):2055-67. PubMed ID: 16250067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of fourth generation cephalosporins against enterobacteriaceae producing extended-spectrum beta-lactamases.
    Sanders CC
    J Chemother; 1996 Feb; 8 Suppl 2():57-62. PubMed ID: 8738847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors involved in the enhanced efficacy against gram-negative bacteria of fourth generation cephalosporins.
    Hancock RE; Bellido F
    J Antimicrob Chemother; 1992 Apr; 29 Suppl A():1-6. PubMed ID: 1601751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of beta-lactamase stability, penetration, and target affinity on the activity of cefazolin, cefamandole, cefoxitin, and cefuroxime.
    Harper PB
    Clin Ther; 1984; 6(3):310-24. PubMed ID: 6609771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains.
    de Sá Del Fiol F; Rocha De Mattos Filho T; Groppo FC
    Braz J Infect Dis; 2000 Feb; 4(1):36-42. PubMed ID: 10788844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrolytic rate at low drug concentration as a limiting factor in resistance to newer cephalosporins.
    Hiraoka M; Inoue M; Mitsuhashi S
    Rev Infect Dis; 1988; 10(4):746-51. PubMed ID: 3055173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outer membrane permeability and beta-lactamase stability of dipolar ionic cephalosporins containing methoxyimino substituents.
    Nikaido H; Liu W; Rosenberg EY
    Antimicrob Agents Chemother; 1990 Feb; 34(2):337-42. PubMed ID: 2109581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phenotypic and genotypic characterization of resistance to third-generation cephalosporins in Enterobacter spp].
    Bertona E; Radice M; Rodríguez CH; Barberis C; Vay C; Famiglietti A; Gutkind G
    Rev Argent Microbiol; 2005; 37(4):203-8. PubMed ID: 16502641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of beta-lactam antibiotics on the in vitro development of resistance in Pseudomonas aeruginosa.
    Carsenti-Etesse H; Cavallo JD; Roger PM; Ziha-Zarifi I; Plesiat P; Garrabe E; Dellamonica P
    Chirurgia (Bucur); 2002; 97(2):151-9. PubMed ID: 12731225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide.
    Drieux L; Brossier F; Sougakoff W; Jarlier V
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():90-103. PubMed ID: 18154532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.